Hepcidin kinetics in hemodialysis patients.

Withdrawn

• Conditions: haemodialysis; 10002086; treatment with artificial kidney; 10038430; 10038365

• Registration Number: NL-OMON34512
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Adult hemodialysis patients (>18 yrs)
hemodialysis for at least 4 months
no IV iron or EPO during experimental dialysis sessions

Exclusion Criteria

malignancies/ overt infection/ hepatic failure, gastro-intestinal bleeding and blood transfusion during the preceding 4 months
no informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Serum and dialysate hepcidin-25 and its two smaller isoforms hepcidin-22 and<br /><br>20.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>